Back to 
Skandinaviska Enskilda Banken AB (publ)
Skandinaviska Enskilda Banken AB (publ)
CORT
Showing 0 of 10 quarters
Position history for Skandinaviska Enskilda Banken AB (publ)'s holdings in Corcept Therapeutics Incorporated.
No. Skandinaviska Enskilda Banken AB (publ) exited its CORT (Corcept Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 43,600 shares worth $1.4M. Skandinaviska Enskilda Banken AB (publ) first reported CORT in Q2 2020 and held it in 8 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.